XUNCE (03317) signed a cooperation framework agreement with the Beijing International Big Data Exchange.
Xunce (03317) announced that the company has formally signed a cooperation framework agreement with Beijing International Data Exchange Limited Liability Company (North Data Exchange). North Data Exchange is a key project in the digital economy field of Beijing to implement the "National Service Industry Expansion and Opening-up Comprehensive Demonstration Zone" and the "China (Beijing) Free Trade Pilot Zone", aiming to become a leading domestic data trading infrastructure and an international hub for cross-border data flow.
XUNCE (03317) announced that the company has officially signed a cooperation framework agreement with Beijing International Big Data Exchange Co., Ltd. (Beijing Data Exchange). Beijing Data Exchange is a key project in the digital economy field implementing the "National Service Industry Expansion and Opening Comprehensive Demonstration Zone" and the "China (Beijing) Free Trade Pilot Zone," aiming to become a leading domestic data trading infrastructure and an important hub for international data cross-border flow.
This cooperation signifies the further deepening of the company's strategic layout in the data element market and national-level data trading platform, marking a key step in the company's data tokenization capabilities in vertical industries, intelligent data circulation, digital asset services, and the collaborative construction of the biological and medical vertical data ecosystem.
According to the strategic cooperation agreement, the company will carry out the following strategic cooperation with Beijing Data Exchange: 1. Collaborative construction of vertical data tokenization landing. Leveraging the company's Tokenization full-chain technology solution and TokenOS operating system technology base, combined with Beijing Data Exchange's core capabilities in high-quality data sets, data compliance registration, trusted circulation, and asset operation, the cooperation aims to achieve enterprise-private data compliance packaging, trusted measurement, asset revitalization, improve data element compliance circulation and value realization links, and support the tokenization and marketization of data applications in industries such as healthcare, finance, and education.
2. Intelligent Siasun Robot & Automation data circulation and industrial empowerment. Fully leveraging the company's advantages in multi-dimensional data collection and accumulation of customer behavior, market dynamics, and software-hardware interaction, the cooperation aims to jointly develop coordination and cooperation around human-shaped Siasun Robot & Automation industrial data, special operation Siasun Robot & Automation data, and core components data to build high-quality, large-scale, compliant circulation, and basic data service capabilities.
3. Co-build digital asset service system. Based on the group's rich experience and intelligent analysis capabilities in the financial data service field, and integrating Beijing Data Exchange's professional capabilities in asset full-process compliance, product design, and asset operation, the two parties will create an intelligent digital asset service system for financial institutions, develop innovative digital financial products, and provide services to improve the efficiency of financial resource allocation for real economy enterprises.
4. Collaborative construction of digitalization in the biopharmaceutical industry and vertical data ecosystem. The two parties will build standardized industry databases for medical research and development, clinical trials, and manufacturing processes, connect with overseas pharmaceutical patents and publicly available research and development production data, and carry out specialized work on data governance and compliant labeling. Meanwhile, relying on exclusive AI models polished with vertical industry corpora, integrated industry computing resources, and create a standardized token service system for the biopharmaceutical industry, promoting industry data circulation, cross-border data applications, and empowering the digital transformation and upgrade of the pharmaceutical industry.
Related Articles

COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.

REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.

HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.

REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.

HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.

RECOMMEND





